A citation-based method for searching scientific literature

Raffaele Frazzi. Cell Biosci 2021
Times Cited: 42







List of co-cited articles
73 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Cancer Statistics, 2021.
Rebecca L Siegel, Kimberly D Miller, Hannah E Fuchs, Ahmedin Jemal. CA Cancer J Clin 2021
14

Robust enumeration of cell subsets from tissue expression profiles.
Aaron M Newman, Chih Long Liu, Michael R Green, Andrew J Gentles, Weiguo Feng, Yue Xu, Chuong D Hoang, Maximilian Diehn, Ash A Alizadeh. Nat Methods 2015
11

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
11

Inferring tumour purity and stromal and immune cell admixture from expression data.
Kosuke Yoshihara, Maria Shahmoradgoli, Emmanuel Martínez, Rahulsimham Vegesna, Hoon Kim, Wandaliz Torres-Garcia, Victor Treviño, Hui Shen, Peter W Laird, Douglas A Levine,[...]. Nat Commun 2013
11

New insight into BIRC3: A novel prognostic indicator and a potential therapeutic target for liver cancer.
Pei-Yao Fu, Bo Hu, Xiao-Lu Ma, Zhang-Fu Yang, Min-Cheng Yu, Hai-Xiang Sun, Ao Huang, Xin Zhang, Jian Wang, Zhi-Qiang Hu,[...]. J Cell Biochem 2019
18
22

ATM mutation rather than BIRC3 deletion and/or mutation predicts reduced survival in 11q-deleted chronic lymphocytic leukemia: data from the UK LRF CLL4 trial.
Matthew J J Rose-Zerilli, Jade Forster, Helen Parker, Anton Parker, Ana E Rodríguez, Tracy Chaplin, Anne Gardiner, Andrew J Steele, Andrew Collins, Bryan D Young,[...]. Haematologica 2014
57
7

A review of cancer immunotherapy toxicity.
Lucy Boyce Kennedy, April K S Salama. CA Cancer J Clin 2020
373
7

BIRC3 is a novel driver of therapeutic resistance in Glioblastoma.
Dapeng Wang, Anders Berglund, Rajappa S Kenchappa, Peter A Forsyth, James J Mulé, Arnold B Etame. Sci Rep 2016
50
7

Colorectal cancer.
Evelien Dekker, Pieter J Tanis, Jasper L A Vleugels, Pashtoon M Kasi, Michael B Wallace. Lancet 2019
7

Survivin at a glance.
Sally P Wheatley, Dario C Altieri. J Cell Sci 2019
146
7

GSVA: gene set variation analysis for microarray and RNA-seq data.
Sonja Hänzelmann, Robert Castelo, Justin Guinney. BMC Bioinformatics 2013
7

A Pan-Cancer Analysis of the BIRC Gene Family and Its Association with Prognosis, Tumor Microenvironment, and Therapeutic Targets.
Shaobo Wu, Qijuan Zang, Zixuan Xing, Xiang Li, Jing Leng, Yanbing Liu, Xiaofei Wang, Juan Yang. Crit Rev Eukaryot Gene Expr 2021
3
100

Biallelic BIRC3 inactivation in chronic lymphocytic leukaemia patients with 11q deletion identifies a subgroup with very aggressive disease.
Sara Raponi, Ilaria Del Giudice, Caterina Ilari, Luciana Cafforio, Monica Messina, Luca V Cappelli, Silvia Bonina, Alfonso Piciocchi, Marilisa Marinelli, Nadia Peragine,[...]. Br J Haematol 2019
7
28

CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009.
Therese A Dolecek, Jennifer M Propp, Nancy E Stroup, Carol Kruchko. Neuro Oncol 2012
4

Colorectal cancer.
Herb Brody. Nature 2015
300
4

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1.
Roel G W Verhaak, Katherine A Hoadley, Elizabeth Purdom, Victoria Wang, Yuan Qi, Matthew D Wilkerson, C Ryan Miller, Li Ding, Todd Golub, Jill P Mesirov,[...]. Cancer Cell 2010
4

Clinical significance of TP53, BIRC3, ATM and MAPK-ERK genes in chronic lymphocytic leukaemia: data from the randomised UK LRF CLL4 trial.
Stuart J Blakemore, Ruth Clifford, Helen Parker, Pavlos Antoniou, Ewa Stec-Dziedzic, Marta Larrayoz, Zadie Davis, Latha Kadalyayil, Andrew Colins, Pauline Robbe,[...]. Leukemia 2020
23
8

Analysis of the inhibitors of apoptosis identifies BIRC3 as a facilitator of malignant progression in glioma.
Loyola V Gressot, Tiffany Doucette, Yuhui Yang, Gregory N Fuller, Ganiraju Manyam, Arvind Rao, Khatri Latha, Ganesh Rao. Oncotarget 2017
26
7


Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia.
Fary Diop, Riccardo Moia, Chiara Favini, Elisa Spaccarotella, Lorenzo De Paoli, Alessio Bruscaggin, Valeria Spina, Lodovico Terzi-di-Bergamo, Francesca Arruga, Chiara Tarantelli,[...]. Haematologica 2020
46
4

The NOTCH Pathway and Its Mutations in Mature B Cell Malignancies.
Francesca Arruga, Tiziana Vaisitti, Silvia Deaglio. Front Oncol 2018
36
5

Comprehensive molecular characterization of inhibitors of apoptosis proteins (IAPs) for therapeutic targeting in cancer.
Jianfeng Liang, Wanni Zhao, Pan Tong, Ping Li, Yuanli Zhao, Hua Li, Jun Liang. BMC Med Genomics 2020
13
15

limma powers differential expression analyses for RNA-sequencing and microarray studies.
Matthew E Ritchie, Belinda Phipson, Di Wu, Yifang Hu, Charity W Law, Wei Shi, Gordon K Smyth. Nucleic Acids Res 2015
4

CD8+ T cell states in human cancer: insights from single-cell analysis.
Anne M van der Leun, Daniela S Thommen, Ton N Schumacher. Nat Rev Cancer 2020
326
4

Alteration of BIRC3 and multiple other NF-κB pathway genes in splenic marginal zone lymphoma.
Davide Rossi, Silvia Deaglio, David Dominguez-Sola, Silvia Rasi, Tiziana Vaisitti, Claudio Agostinelli, Valeria Spina, Alessio Bruscaggin, Sara Monti, Michaela Cerri,[...]. Blood 2011
140
4

Survivin and Tumorigenesis: Molecular Mechanisms and Therapeutic Strategies.
Xun Chen, Ning Duan, Caiguo Zhang, Wentao Zhang. J Cancer 2016
168
4


Survivin: a unique target for tumor therapy.
Himani Garg, Prerna Suri, Jagdish C Gupta, G P Talwar, Shweta Dubey. Cancer Cell Int 2016
242
4

XIAP is a predictor of cisplatin-based chemotherapy response and prognosis for patients with advanced head and neck cancer.
Xi-Hu Yang, Zhi-En Feng, Ming Yan, Sayaka Hanada, Hui Zuo, Cheng-Zhe Yang, Ze-Guan Han, Wei Guo, Wan-Tao Chen, Ping Zhang. PLoS One 2012
48
4

Inhibitor of apoptosis proteins in human health and disease.
Matous Hrdinka, Monica Yabal. Genes Immun 2019
21
9

Survivin and autoimmunity; the ins and outs.
Hamidreza Ebrahimiyan, Saeed Aslani, Nima Rezaei, Ahmadreza Jamshidi, Mahdi Mahmoudi. Immunol Lett 2018
30
6


Live and let die: epigenetic modifications of Survivin and Regucalcin in non-small cell lung cancer tissues contribute to malignancy.
Dörte Nitschkowski, Sebastian Marwitz, Sousana A Kotanidou, Martin Reck, Christian Kugler, Klaus F Rabe, Ole Ammerpohl, Torsten Goldmann. Clin Epigenetics 2019
11
18

Cancer statistics, 2020.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2020
4

Overexpression of cIAP2 contributes to 5-FU resistance and a poor prognosis in oral squamous cell carcinoma.
M Nagata, H Nakayama, T Tanaka, R Yoshida, Y Yoshitake, D Fukuma, K Kawahara, Y Nakagawa, K Ota, A Hiraki,[...]. Br J Cancer 2011
48
4

The biology and management of non-small cell lung cancer.
Roy S Herbst, Daniel Morgensztern, Chris Boshoff. Nature 2018
4

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
4

Essentials of oral cancer.
César Rivera. Int J Clin Exp Pathol 2015
352
4

clusterProfiler: an R package for comparing biological themes among gene clusters.
Guangchuang Yu, Li-Gen Wang, Yanyan Han, Qing-Yu He. OMICS 2012
4

xCell: digitally portraying the tissue cellular heterogeneity landscape.
Dvir Aran, Zicheng Hu, Atul J Butte. Genome Biol 2017
4

TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.
Sanjeev Mariathasan, Shannon J Turley, Dorothee Nickles, Alessandra Castiglioni, Kobe Yuen, Yulei Wang, Edward E Kadel, Hartmut Koeppen, Jillian L Astarita, Rafael Cubas,[...]. Nature 2018
4

Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic.
T A Chan, M Yarchoan, E Jaffee, C Swanton, S A Quezada, A Stenzinger, S Peters. Ann Oncol 2019
4

TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data.
Antonio Colaprico, Tiago C Silva, Catharina Olsen, Luciano Garofano, Claudia Cava, Davide Garolini, Thais S Sabedot, Tathiane M Malta, Stefano M Pagnotta, Isabella Castiglioni,[...]. Nucleic Acids Res 2016
4

Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response.
Peng Jiang, Shengqing Gu, Deng Pan, Jingxin Fu, Avinash Sahu, Xihao Hu, Ziyi Li, Nicole Traugh, Xia Bu, Bo Li,[...]. Nat Med 2018
4

A view on drug resistance in cancer.
Neil Vasan, José Baselga, David M Hyman. Nature 2019
655
4

Top 10 Challenges in Cancer Immunotherapy.
Priti S Hegde, Daniel S Chen. Immunity 2020
553
4

TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2.
Xiaoming Li, Yili Yang, Jonathan D Ashwell. Nature 2002
383
4


In vitro Cell Migration, Invasion, and Adhesion Assays: From Cell Imaging to Data Analysis.
Jordi Pijuan, Carla Barceló, David F Moreno, Oscar Maiques, Pol Sisó, Rosa M Marti, Anna Macià, Anaïs Panosa. Front Cell Dev Biol 2019
154
4

NIH Image to ImageJ: 25 years of image analysis.
Caroline A Schneider, Wayne S Rasband, Kevin W Eliceiri. Nat Methods 2012
4


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.